GlassScriptPhysician profile
Julia Reiser
NPI 1194257774
$5,740.54
in general payments reported to CMS, 2019-2025
11 companies · $672 in 2025
The $672 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,127 · 2023: $1,733 · 2024: $1,208 · 2025: $672.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,963 · Food and Beverage: $1,413 · Education: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,962.55 |
| Food and Beverage | $1,412.52 |
| Education | $238.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,103.45 | 2022-2023 | Evos, Trigen |
| Synthes Gmbh | $1,043.61 | 2024 | |
| Stryker Corporation | $435.65 | 2022-2025 | Variax, Aequalis Ascend Flex |
| Si-Bone, INC. | $289.45 | 2022 | |
| Skeletal Dynamics INC | $241.02 | 2023-2025 | Implate, Geminus, Ijs |
| Acera Surgical, INC. | $237.16 | 2025 | Restrata Wound Matrix |
| Baxter Healthcare | $140.43 | 2023-2025 | Perclot, Tisseel |
| Flower Orthopedics Coporation | $111.85 | 2025 | |
| Depuy Synthes Sales INC. | $85.41 | 2023-2024 | Unium, Lcp, Va-Lcp |
| Biocomposites INC | $32.86 | 2024 | |
| Ferring Pharmaceuticals INC. | $19.65 | 2025 | Euflexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Reiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.